Exenatide
BASIC2
AstraZeneca · Phase 3 · Active, not recruiting · Enrollment 63
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Exenatide once weekly extended-release | Obesity or overweight | n/r | 24 | n/r | n/r |
| Matching placebo | Obesity or overweight | n/r | 24 | n/r | n/r |